In this issue:
‘Watch and wait’ after CRT for LARC
Prescription medication use & polypharmacy in cancer survivors
High rates of anxiety/depression among CRC survivors
Chromosome loss linked to improved PFS with bevacizumab
Oral fruquintinib improves survival in pretreated mCRC
Explaining ongoing fatigue among CRC survivors
Use fully dosed adjuvant chemotherapy in obese colon cancer patients
Naldemedine: QOL benefits in opioid-induced constipation
Assessing breakthrough-designated cancer drugs
Temozolomide regimen in MGMTmethylated, MMR-proficient mCRC
Please login below to download this issue (PDF)